A regulatory system for approving new drugs is certainly necessary, says In the Pipeline's Derek Lowe, but is it the right system? Lowe references an article at BioCentury that suggests an adaptive system instead of one that makes binary decisions. In other words, Lowe says, the idea is to set things up so that data can be generated quickly, that decisions can be made on that data, and then modified when additional findings come out.